We describe that no particular clinical phenotype is associated with SOCS1 mutant cHL patients and found that the SOCS1 mutation type is a single-gene prognostic biomarker in a subset of cHL patients. The gene discussed is SOCS1; the disease is classic Hodgkin lymphoma.